The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.

ResearchAbout

Latest News & Publications

Christian Happi wins 2019 HUGO African Prize

The Human Genome Organization (HUGO) has conferred its 2019 HUGO African Prize award to VHFC researcher Prof. Christian Happi, who is professor of Molecular Biology and Director at Redeemer’s University and Director of the World Bank funded African Center of...

New disease surveillance tool published in Nature Biotechnology

During the Zika virus outbreak of 2015–16, public health officials scrambled to contain the epidemic and curb the pathogen’s devastating effects on pregnant women. At the same time, scientists around the globe tried to understand the genetics of this mysterious virus....

Lassa-Fighting Legacy: Forgotten man, forgotten disease

Ars Technica recently published an in-depth article on the history of Lassa fever in Sierra Leone, highlighting the important role that Dr. Aniru Conteh, a senior physician at the Kenema Government Hospital's Lassa ward, played in treating Lassa patients both during...